Selexis And Generium Launch Omalizumab Biosimilar In Russia

Xolair Rival Is Third Biosimilar Developed By Firms With SUREtechnology Platform

 
• By David Wallace
  
Russia Map Flag
Selexis and Generium introduce omalizumab in Russia • Source: PSL Images RF / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products